Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01934335
Title Effect of Vandetanib on Cellular Markers in Invasive Breast Cancer
Recruitment Terminated
Gender female
Phase Phase I
Variant Requirements No
Sponsors NCT01934335
Indications

breast cancer

Therapies

Vandetanib

Age Groups: adult
Covered Countries USA


No variant requirements are available.